Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer

Featuring perspectives from Dr Harold J Burstein, Ms Kelly Fischer, Dr Komal Jhaveri and Ms Melissa Rikal, including the following topics:

Introduction (0:00)

The Utility of Genomic Assays in Treatment Decision-Making for HR-Positive, HER2-Negative Localized Breast Cancer (10:21)

The Role of CDK4/6 Inhibitors in Therapy for HR-Positive Breast Cancer (37:18)

Oral Selective Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer (mBC) (1:04:27)

Alpelisib and Capivasertib in Treatment for HR-Positive mBC (1:28:40)

NCPD information and select publications

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.